| Metric | შპს ფარმაცევტული სახლი + | სს საქართველოს ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾61.6m₾65.5m | ₾2.32bn₾1.91bn |
| Revenue growth | -5.8% | 21.1% |
| Profitability | ||
| EBITDA | -₾11.7m-₾2.7m | — |
| EBITDA margin | -18.9%-4.1% | — |
| Net profit | -₾11.2m-₾3.1m | ₾1.33bn₾992.0m |
| Net margin | -18.2%-4.8% | 57.6%51.9% |
| Balance sheet | ||
| Total assets | ₾66.5m₾48.9m | ₾31.39bn₾28.37bn |
| Total equity | -₾17.3m-₾6.0m | ₾4.45bn₾3.79bn |
| ROE | — | 30.0%26.2% |